CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Gift Director gave 84,852 shares (gift)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Senior VP, Chief Pharma Dev. sold 1,036 shares at $231.34 ($239,668)
- 4 Planned sale Director sold 22,489 shares at an average $212.88 ($4,787,404)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Agreement ended · Other events
- 424B3 Offering Prospectus
- 424B5 Offering Prospectus
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Pres., R&D, and CMO sold 2,676 shares at an average $245.99 ($658,258)
- 4 Planned sale Director sold 26,270 shares at an average $246.19 ($6,467,491)
- 4 Planned sale Pres., R&D, and CMO sold 73,888 shares at an average $243.92 ($18,022,588)
Page 13 of 62 · 1,224 filings